Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Other hematologic neoplasm 1

Conditions

Neoplasm Metastasis 1

Interventions

pembrolizumab 26 Specimen Handling 22 Biopsy 22 Magnetic Resonance Spectroscopy 20 Paclitaxel 12 Standard of Care 10 Carboplatin 10 Blood Specimen Collection 10 Bevacizumab 10 atezolizumab 9 Nivolumab 9 Cisplatin 8 Radiosurgery 7 Pemetrexed 7 Capecitabine 7 Surveys and Questionnaires 6 Gemcitabine 6 Cyclophosphamide 6 trastuzumab deruxtecan 5 durvalumab 5 X-Rays 5 Taxes 5 Radiotherapy 5 Irinotecan 5 Fluorouracil 5 olaparib 4 niraparib 4 cabozantinib 4 Oxaliplatin 4 Leucovorin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

siremadlin × Tumor-Agnostic × 90 days × Clear all

NCT04116541 2026-04-24

MegaMOST

Centre Leon Berard

Phase 2 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡